Standardised microalgae biomass for research and development

Spirulina and chlorella biomass from controlled cleanroom production – with batch-specific analytics, documented quality and reproducible specifications.

Request a sample

Market challenges

  • need for reproducible biological starting materials
  • high requirements for traceability and documentation
  • project-specific alignment of product form and target properties
  • traceable process data for development and validation processes
  • flexible supply for R&D samples, screening approaches and pilot programmes
  • defined documentation packages by individual agreement
  • technical collaboration on evaluation, process integration and scaling

Our advantages

  • controlled production in a defined cleanroom environment
  • spirulina and chlorella as fresh/paste or concentrate
  • project-specific alignment of target properties and scope of documentation
  • batch-level traceability via batch ID
  • CoAs and supplementary documentation as agreed
  • suitable for R&D samples, screening approaches and pilot programmes
  • audit support on request

Documented quality for controlled development processes

ALGENE provides standardised microalgae biomass for pharma-related research, development and validation processes. The focus is not on end products or medical claims, but on defined starting materials with traceable origin, documented procedures and project-specific alignment.

Through controlled production, QC/QA processes and batch-level traceability, ALGENE creates a robust basis for partners who need to work with reproducible biological raw materials.

Spirulina / Chlorella

Product forms & specifications

Note: Specific target parameters are agreed per application (e.g. colour target, particle range, microbiological limits). The structure of the specification is shown below.

  • Spirulina / Chlorella – Fresh/Paste
    • Use: shots/drinks, pastes/pre-mixes, fermentation, formulation trials, pilot batches
    • Target properties: consistency, viscosity and concentration range according to target application, colour green/turquoise-green for spirulina, green for chlorella, documentation as agreed
    • Particles: adjustable depending on customer and process, homogenised pastes, defined process integration
    • Quality testing: testing and release according to an individually agreed specification, relevant parameters defined per project
    • Packaging & logistics: refrigerated supply chain, container sizes and shelf life as agreed
    Spirulina / Chlorella – Fresh/Paste
  • Spirulina / Chlorella – Concentrate
    • Use: colour and biomass component in liquid products, functional beverages, pre-mixes, process integration
    • Target properties: defined concentration range according to target application, stable dispersion, adjustable viscosity, species-specific colour profile
    • Parameters: colour and concentration profile documentable as agreed, pH window definable per application
    • Quality testing: testing and release according to an individually agreed specification, relevant parameters defined per project
    • Logistics: refrigerated or ambient delivery depending on formulation and stability requirements, container sizes as agreed
    Spirulina / Chlorella – Concentrate

Quality & Compliance

ALGENE produces in closed systems within a controlled cleanroom environment. For pharma-related applications, the focus is on traceability, documentation and reproducible process conditions.

CoAs, test reports and supplementary documentation can be provided per project and per batch. The scope and depth of documentation are defined as part of the supply agreement.

Quality and documentation structure:

  • controlled cleanroom production according to GMP cosmetics standards
  • structured standard operating procedures (SOPs)
  • digital documentation of relevant production data
  • batch-level traceability via batch ID
  • project-specific scope of testing and release
  • documented change control process
  • audit support and supplementary documents on request

Applications

Examples & formulation

ALGENE supports partners in the life sciences sector in defining and validating microalgae-based starting materials. The focus is on reproducible target properties, project-specific documentation and a structured transition from sample and pilot quantities to robust development processes.

The collaboration is defined per project and can include sample provision, alignment of target properties, validation approaches, stability assessment and documentation packages.

Typical co-development steps:

  • classify target profile and application context
  • select a suitable product form
  • agree on target properties and scope of documentation
  • provide samples or a pilot batch
  • evaluate process and stability behaviour
  • prepare delivery and documentation model

R&D screenings

Standardised spirulina or chlorella biomass for early development and screening processes, with batch-level documentation, a defined product form and analytical support.

Pilot batches & validation

Samples and pilot batches for testing process capability, stability and specification profiles, including CoA, batch ID and defined test parameters.

Analytical reference samples

Reproducible biomass batches for internal development programmes, comparative analyses and partner processes subject to documentation requirements.